Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SurgePays ( (SURG) ) has provided an announcement.
On August 5, 2025, SurgePays, Inc. entered into an At The Market Offering Agreement with Titan Partners Group LLC to potentially sell shares of its common stock, with an aggregate offering price of up to $15 million. The proceeds from the offering, if any, will be used for the expansion of SurgePays’ Lifeline business, working capital, and general corporate purposes, potentially impacting its market positioning and operations.
The most recent analyst rating on (SURG) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on SurgePays stock, see the SURG Stock Forecast page.
Spark’s Take on SURG Stock
According to Spark, TipRanks’ AI Analyst, SURG is a Neutral.
SurgePays has potential growth opportunities highlighted by strategic partnerships and expansions, supported by recent financing. However, its financial performance is concerning, with declining revenues and profitability issues. The technical outlook is stable but cautious, and the valuation remains weak due to ongoing losses.
To see Spark’s full report on SURG stock, click here.
More about SurgePays
SurgePays, Inc. operates in the telecommunications industry, focusing on providing services such as the Lifeline program, which aims to expand access to telecommunications services. The company is involved in offering and selling shares of its common stock to raise capital for business expansion and general corporate purposes.
Average Trading Volume: 131,696
Technical Sentiment Signal: Sell
Current Market Cap: $55.11M
For a thorough assessment of SURG stock, go to TipRanks’ Stock Analysis page.